Harbor Capital Advisors Inc. Has $7.74 Million Stock Holdings in Addus HomeCare Corporation $ADUS

Key Points

• Harbor Capital Advisors Inc. increased its holdings in Addus HomeCare by 4.5%, now owning 67,219 shares valued at approximately $7.74 million.
• Insider transactions revealed significant sales, with Director Veronica Hill-Milbourne and EVP Brian Poff selling shares worth over $1 million combined in August.
• Addus HomeCare reported a strong quarterly performance, with $1.49 EPS exceeding estimates, and a 21.8% year-over-year revenue increase to $349.44 million.

Harbor Capital Advisors Inc. lifted its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 4.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 67,219 shares of the company's stock after purchasing an additional 2,906 shares during the period. Harbor Capital Advisors Inc. owned 0.37% of Addus HomeCare worth $7,743,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of ADUS. BI Asset Management Fondsmaeglerselskab A S acquired a new position in Addus HomeCare in the 1st quarter valued at about $41,000. Caitong International Asset Management Co. Ltd grew its stake in Addus HomeCare by 368.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,255 shares of the company's stock valued at $124,000 after buying an additional 987 shares during the last quarter. Bailard Inc. acquired a new position in Addus HomeCare in the 1st quarter valued at about $208,000. Heritage Family Offices LLP grew its position in shares of Addus HomeCare by 6.3% during the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock worth $239,000 after purchasing an additional 143 shares in the last quarter. Finally, Private Advisor Group LLC grew its position in shares of Addus HomeCare by 52.4% during the 1st quarter. Private Advisor Group LLC now owns 2,546 shares of the company's stock worth $252,000 after purchasing an additional 875 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company's stock.

Insider Activity

In other news, Director Veronica Hill-Milbourne sold 1,571 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $114.93, for a total value of $180,555.03. Following the sale, the director owned 5,067 shares of the company's stock, valued at $582,350.31. The trade was a 23.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Brian Poff sold 7,739 shares of the business's stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $116.82, for a total transaction of $904,069.98. Following the transaction, the executive vice president directly owned 56,980 shares of the company's stock, valued at approximately $6,656,403.60. This represents a 11.96% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 34,310 shares of company stock valued at $3,958,375 over the last quarter. Company insiders own 4.50% of the company's stock.

Addus HomeCare Trading Down 0.9%

ADUS opened at $109.27 on Tuesday. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $136.72. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17. The company has a fifty day moving average of $111.95 and a 200-day moving average of $107.38. The stock has a market cap of $2.01 billion, a PE ratio of 24.12, a price-to-earnings-growth ratio of 1.68 and a beta of 0.85.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The company reported $1.49 EPS for the quarter, topping analysts' consensus estimates of $1.45 by $0.04. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The business had revenue of $349.44 million during the quarter, compared to analysts' expectations of $345.71 million. During the same period last year, the company posted $1.35 earnings per share. The business's quarterly revenue was up 21.8% on a year-over-year basis. On average, sell-side analysts predict that Addus HomeCare Corporation will post 4.59 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have issued reports on ADUS. Wall Street Zen upgraded shares of Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Sunday, June 29th. TD Cowen increased their target price on shares of Addus HomeCare from $135.00 to $139.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Macquarie reaffirmed an "outperform" rating and set a $133.00 price target on shares of Addus HomeCare in a report on Tuesday, June 10th. UBS Group initiated coverage on shares of Addus HomeCare in a report on Tuesday, September 2nd. They set a "buy" rating and a $145.00 price target for the company. Finally, Barclays upped their price target on shares of Addus HomeCare from $83.00 to $109.00 and gave the stock an "underweight" rating in a report on Tuesday, August 19th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Addus HomeCare has an average rating of "Buy" and a consensus price target of $138.89.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.